DNB Carnegie has lowered the target price for Hiab to 55 euros, down from the previous target of 60 euros, while maintaining its buy recommendation.
DNB Carnegie has reduced the target price for Hiab to 55 euros (previously 60), but continues to reiterate its buy rating.

















